Liposomes containing NY‑ESO‑1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines. (Q51075893)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2014

Language	Label	Description	Also known as
English	Liposomes containing NY‑ESO‑1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines.	scientific article published in April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

Liposomes containing NY‑ESO‑1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

1 reference

based on heuristic

inferred from title

Fernando Albericio

5

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

author name string

Luis J Cruz

1

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

Felix Rueda

2

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

Lorena Simón

3

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

Begoña Cordobilla

4

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

Joan C Domingo

6

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

publication date

1 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

9

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

4

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

435-449

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Enhancing immune responses to tumor-associated antigens

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Identification of tumor antigens and T-cell epitopes, and its clinical application

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Dendritic cell-based therapeutic cancer vaccines: what we have and what we need

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

The perfect mix: recent progress in adjuvant research

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Designing vaccines based on biology of human dendritic cell subsets

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

IFN-α Skews Monocyte Differentiation into Toll-Like Receptor 7-Expressing Dendritic Cells with Potent Functional Activities

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Establishment of Schistosoma japonicum calpain-specific mouse T cell hybridomas and identification of a T cell epitope that stimulates IFNgamma production

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

IFN-alpha in the generation of dendritic cells for cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

The IL-1 family: regulators of immunity

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Cytokines as vaccine adjuvants: interleukin 1 and its synthetic peptide 163-171.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Expression of biologically active human interleukin 1 subpeptides by transfected simian COS cells

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Fc receptors for IgG and antigen presentation on MHC class I and class II molecules

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Human antibody-Fc receptor interactions illuminated by crystal structures

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc gamma receptors

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Lipopeptide vaccines--yesterday, today, and tomorrow

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

The validity of predicted T-cell epitopes.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Lysosomal cysteine proteases (cathepsins): promising drug targets.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Liposomal delivery of CTL epitopes to dendritic cells

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Monophosphoryl Lipid A (MPL) as an Adjuvant for Anti-Cancer Vaccines: Clinical Results

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Production of antibodies with peptide-CpG-DNA-liposome complex without carriers

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Preparation of immunoliposomes bearing poly(ethylene glycol)-coupled monoclonal antibody linked via a cleavable disulfide bond for ex vivo applications

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.66

21 January 2018

Identifiers

10.2217/NNM.13.66

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24910875

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51075893&oldid=1790647832"